23/10/2025
Laminitis remains one of the most devastating conditions in equine health, but new science is changing that.
Over the past several years, our team at Byrock Technologies has carried out extensive research to develop a novel therapy designed to protect and preserve hoof tissue affected by laminitis.
That research has now been featured by TheHorse.com, highlighting our breakthrough work and what it could mean for horses and the people who care for them.
We’re proud to see our efforts recognised and to continue moving this innovation toward real-world use and global adoption. 🐴
🔗 Read the full article below
Scientists believe a new drug, methylated tirilazad, could be an option for treating laminitis in horses, noting additional research is needed.
